High-purity production and precise editing of DNA base editing ribonucleoproteins
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Cytosine and adenine base editor ribonucleoproteins show precise base editing with reduced DNA and RNA off-target effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The additional step of producing purified protein may be cost-prohibitive due to the insolubility of the protein, so any purchased ABE enzyme in mRNA or protein format is usually custom-ordered.45”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437 · cited 2×
“CBEs include uracil DNA glycosylase inhibitor (UGI) to improve editing efficiency (25, 27).”
BackgroundMethodProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184 · cited 2×
“To this end, we tested ABE RNPs targeting 19 different endogenous sites (23, 24) and CBE RNPs targeting 8 different endogenous sites (25, 26) in HEK293T cells.”
MethodKim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856 · cited 1×
“In contrast, the delivery of base editor–sgRNA ribonucleoprotein (RNP) complexes can reduce off-target effects (12, 20) because the RNPs are transiently active and rapidly degraded by endogenous cellular proteases (21).”
BackgroundSelf-citationZuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460 · cited 1×
“In contrast, the delivery of base editor–sgRNA ribonucleoprotein (RNP) complexes can reduce off-target effects (12, 20) because the RNPs are transiently active and rapidly degraded by endogenous cellular proteases (21).”
BackgroundEngineered CRISPR-Cas9 nuclease with expanded targeting space
Nishimasu, H., Shi, X., Ishiguro, S., Gao, L., Hirano, S., Okazaki, S., Noda, T., Abudayyeh, O. O., Gootenberg, J. S., Mori, H., et al. (2018) · Science · doi:10.1126/science.aas9129 · Cited by 1,100
Richter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G. A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer, D. E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0453-z · Cited by 1,020
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
Koblan, L. W., Doman, J. L., Wilson, C., Levy, J. M., Tay, T., Newby, G. A., Maianti, J. P., Raguram, A., & Liu, D. R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4172 · Cited by 944
Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion
Zong, Y., Wang, Y., Li, C., Zhang, R., Chen, K., Ran, Y., Qiu, J.-L., Wang, D., & Gao, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3811 · Cited by 866
Targeted base editing in rice and tomato using a CRISPR-Cas9 cytidine deaminase fusion
Shimatani, Z., Kashojiya, S., Takayama, M., Terada, R., Arazoe, T., Ishii, H., Teramura, H., Yamamoto, T., Komatsu, H., Miura, K., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3833 · Cited by 812
Komor, A. C., Zhao, K. T., Packer, M. S., Gaudelli, N. M., Waterbury, A. L., Koblan, L. W., Kim, Y. B., Badran, A. H., & Liu, D. R. (2017) · Science Advances · doi:10.1126/sciadv.aao4774 · Cited by 783
Cited by
Engineered Virus-like Particles for Efficient in Vivo Delivery of Therapeutic Proteins
Banskota, S., Raguram, A., Suh, S., Du, S. W., Davis, J. R., Choi, E. H., Wang, X., Nielsen, S. C., Newby, G. A., Randolph, P. B., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.021 · Cited by 668
“In contrast, transient eVLP-mediated delivery of BE RNPs greatly reduces the opportunity for off-target editing, as we showed both in vitro and in vivo (Figures 3G, 3H, and 6D).”
BackgroundResultInfluentialTherapeutic in vivo delivery of gene editing agents
Raguram, A., Banskota, S., & Liu, D. R. (2022) · Cell · doi:10.1016/j.cell.2022.03.045 · Cited by 522
“We recently developed engineered VLPs (eVLPs) based on Moloney MLV (MMLV) that package Cas9 nuclease or base editor RNPs and mediate potent, therapeutic levels of gene editing across multiple organs in mice (Banskota et al., 2022).”
BackgroundInfluentialGene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Khoshandam, M., Soltaninejad, H., Mousazadeh, M., Hamidieh, A. A., & Hosseinkhani, S. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.027 · Cited by 152
Hołubowicz, R., Du, S. W., Felgner, J. H., Šmidák, R., Choi, E. H., Palczewska, G., Menezes, C. R., Dong, Z., Gao, F., Medani, O., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01296-2 · Cited by 118
“Consequently, non-viral delivery methods such as LNPs, silica nanocapsules, eVLPs and RNP delivery have been developed 28,35,40,75–81 .”
Intracellular Protein Delivery: Approaches, Challenges, and Clinical Applications
Chan, A., & Tsourkas, A. (2023) · BME Frontiers · doi:10.34133/bmef.0035 · Cited by 99
“…was achieved when 10% to 20% molar percentage of DOTAP was incorporated into LNP formulations owing to increased electrostatic complexation with negatively charged RNPs. Gene editing of other organs including the eye have also been demonstrated via local injection of lipid:RNP complexes [174,175].”
BackgroundAntoniou, P., Hardouin, G., Martinucci, P., Frati, G., Félix, T., Chalumeau, A., Fontana, L., Martin, J., Masson, C., Brusson, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34493-1 · Cited by 88
Targeted nonviral delivery of genome editors in vivo
Tsuchida, C. A., Wasko, K. M., Hamilton, J. R., & Doudna, J. A. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307796121 · Cited by 90
LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea
Mohanna, S. Z. M., Djaksigulova, D., Hill, A. M., Wagner, P. K., Simpson, E. M., & Leavitt, B. R. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.042 · Cited by 79
Xu, W., Zhang, S., Qin, H., & Yao, K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05957-3 · Cited by 84
Improvement of base editors and prime editors advances precision genome engineering in plants
Hua, K., Han, P., & Zhu, J. (2021) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiab591 · Cited by 66
Hong, S.-A., Kim, S., Lee, A.-Y., Hwang, G., Kim, J. H., Iwata, H., Kim, S., Bae, S., & Lee, S. E. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.005 · Cited by 64
Self-citationJo, D. H., Jang, H.-K., Cho, C. S., Han, J. H., Ryu, G., Jung, Y., Bae, S., & Kim, J. H. (2023) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2022.11.021 · Cited by 59
“ABE RNP recovered RPE65 protein expression in RPE cells but failed to recover ERG responses.(17) Still, novel delivery methods are required to enhance the editing efficiency of ABE RNP, which makes AAV-ABE a more plausible method of clinical application in the current status.”
BackgroundMethodSelf-citationDNA base editing in nuclear and organellar genomes
Tan, J., Forner, J., Karcher, D., & Bock, R. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.06.015 · Cited by 61
Precision genome editing in the eye
Suh, S., Choi, E. H., Raguram, A., Liu, D. R., & Palczewski, K. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210104119 · Cited by 54
“(48) demonstrated that ABE:sgRNA RNPs could be delivered to rd12 mice using lipofectamine when administered subretinally, documenting nonviral base editing in the eye.”
Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins
Xu, D. Z., Besselink, S., Ramadoss, G. N., Dierks, P. H., Lubin, J. P., Pattali, R. K., Brim, J. I., Christenson, A. E., Colias, P. J., Ornelas, I. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63167-x · Cited by 67
Genome editing in the treatment of ocular diseases
Choi, E. H., Suh, S., Sears, A. E., Hołubowicz, R., KEDHAR, S. R., Browne, A., & Palczewski, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01057-2 · Cited by 57
Gene therapy for monogenic disorders: challenges, strategies, and perspectives
Zhang, Y., & Wu, Z. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.08.001 · Cited by 46
Current developments of gene therapy in human diseases
Liu, F., Li, R., Zhu, Z., Yang, Y., & Lu, F. (2024) · MedComm · doi:10.1002/mco2.645 · Cited by 48
Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
Ail, D., Malki, H., Zin, E. A., & Dalkara, D. (2023) · The Application of Clinical Genetics · doi:10.2147/tacg.s383453 · Cited by 40
“8% and 6% efficiency, respectively, leading to phenotype improvement only with AAV-ABEs suggesting a better clinical relevance.(62,88) These advances are encouraging and their development in parallel with that of AAV approaches is crucial to develop safer therapeutic methods.”
BackgroundSalman, A., Kantor, A., McClements, M. E., Marfany, G., Trigueros, S., & MacLaren, R. E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091842 · Cited by 37
Genome Editing, A Superior Therapy for Inherited Retinal Diseases
Yan, A. L., Du, S. W., & Palczewski, K. (2022) · Vision Research · doi:10.1016/j.visres.2023.108192 · Cited by 40
Packaged delivery of CRISPR–Cas9 ribonucleoproteins accelerates genome editing
Karp, H., Zoltek, M., Wasko, K. M., Vazquez, A. L., Brim, J. I., Ngo, W., Schepartz, A., & Doudna, J. A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf105 · Cited by 42
“Consistent with previous research [ 3–5 ], RNP delivery by either strategy resulted in improved editing specificity compared to extended lentiviral expression ( Supplementary Fig.”
InfluentialEngel, N. W., Steinfeld, I., Ryan, D., Anupindi, K., Kim, S., Wellhausen, N., Chen, L., Wilkins, K., Baker, D. J., Rommel, P. C., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2427216122 · Cited by 42
“In the future, the selection of base editors with improved specificity ( 63 ), and RNP - complex delivery of base editor proteins ( 38 ) may reduce this gap.”
Zuo, Y., Zhang, C., Zhou, Y., Li, H., Xiao, W., Herzog, R. W., Xu, J., Zhang, J., Chen, Y. E., & Han, R. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01036-0 · Cited by 34
Base editors: development and applications in biomedicine
Liang, Y., Chen, F., Wang, K., & Lai, L. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1013-y · Cited by 35
Breaking genetic shackles: The advance of base editing in genetic disorder treatment
Xu, F., Zheng, C., Xu, W., Zhang, S., Liu, S., Chen, X., & Yao, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1364135 · Cited by 34
Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review
Finocchio, L., Zeppieri, M., Gabai, A., Toneatto, G., Spadea, L., & Salati, C. (2023) · Biomedicines · doi:10.3390/biomedicines11123221 · Cited by 34
“Numerous lipid-based drugs designed for eye diseases are accessible for transporting CRISPR or ribonucleoproteins for base editing [136,137].”
BackgroundBasic Principles and Clinical Applications of CRISPR-Based Genome Editing
Lim, J. M., & Kim, S. (2022) · Yonsei Medical Journal · doi:10.3349/ymj.2022.63.2.105 · Cited by 28
Gene editing innovations and their applications in cardiomyopathy research
Kyriakopoulou, E., Monnikhof, T., & van Rooij, E. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050088 · Cited by 29
Carvalho, C., Lemos, L., Antas, P., & Seabra, M. C. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1270561 · Cited by 21
Lu, Y., Mbakam, C. H., Song, B., Bendavid, E., & Tremblay, J. P. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.892769 · Cited by 24
“Other studies have shown that over-expression of Uracil DNA glycosylase inhibitor (UGI) increased the purity of BE products in human cells (Komor et al., 2017; Jiang et al., 2018; Jang et al., 2021) In FIGURE 2 (A) represents a basic principle of base editor which is made of sgRNA that target a specific DNA sequence,…”
BackgroundA chemically controlled Cas9 switch enables temporal modulation of diverse effectors
Wei, C. T., Popp, N. A., Peleg, O., Powell, R. L., Borenstein, E., Maly, D. J., & Fowler, D. M. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01278-6 · Cited by 22
Multiplex base editing to convert TAG into TAA codons in the human genome
Chen, Y., Hysolli, E., Chen, A., Casper, S., Liu, S., Yang, Y., Liu, C., & Church, G. M. (2022) · Nature Communications · doi:10.1038/s41467-022-31927-8 · Cited by 24
Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing
Jang, G., Shin, H. R., Do, H., Kweon, J., Hwang, S., Kim, S.-Y., Heo, S. H., Kim, Y., & Lee, B. H. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.02.009 · Cited by 20
Africanizing genome editing for food sustainability
Runo, S. M., Karembu, M., Nang'ayo, F. L. O., Mekbib, F., Haileselassie, T., Tesfaye, K., Lasky, J. R., Gao, H., & Jones, T. J. (2024) · Global Food Security · doi:10.1016/j.gfs.2024.100785 · Cited by 18
In vivo application of base and prime editing to treat inherited retinal diseases
Jo, D. H., Bae, S., Kim, S., Kim, J., & Kim, J. H. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101132 · Cited by 17
Self-citationMurugesan, R., Karuppusamy, K. V., Marepally, S. K., & Thangavel, S. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1148693 · Cited by 15
“Although recombinant protein delivery of base editors has been reported, the production of the recombinant protein is technically challenging (Jang et al., 2021; Knipping et al., 2022).”
BackgroundLarge-scale manufacturing of base-edited chimeric antigen receptor T cells
Woodruff, R., Parekh, F., Lamb, K., Mekkaoui, L., Allen, C. G., Smetanova, K., Huang, J. L., Williams, A., Toledo, G. S., Lilova, K., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101123 · Cited by 16
“18,32 Messenger RNA delivery is the favored approach due to challenges with purifying the base editor protein 37 and the cost of producing AAV.”
BackgroundMethodKim, S., Jeong, Y. K., Cho, C. S., Lee, S., Sohn, C. H., Kim, J. H., Jeong, Y., Jo, D. H., Bae, S., & Lee, H. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201825 · Cited by 14
Self-citationEfficient base editing and development in human embryos without chromosomal alterationsPreprint
Jerabek, S., Kim, J., Sung, J., Jung, C., Kulmann, M. I. R., Isado, M., Jang, H.-S., Li, M., Bhatele, S., Kappy, M. D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.30.728989 · Cited by 15
Self-citationPulman, J., Botto, C., Malki, H., Ren, D., Oudin, P., De Cian, A., As, M., Izabelle, C., Saubamea, B., Forster, V., et al. (2024) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2024.102349 · Cited by 12
“28 In our work, naked RNPs were able to yield up to fi ve times more base editing in the whole neural retina.”
Adair, B., Korecki, A. J., Djaksigulova, D., Wagner, P. K., Chiu, N. Y., Lam, S. L., Lengyell, T. C., Leavitt, B. R., & Simpson, E. M. (2023) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00729-6 · Cited by 12
“chemically modified single-guide RNAs (sgRNAs), improving on-target editing and safety by minimizing off-target editing [46, 47].”
BackgroundShining light on CRISPR/Cas9 therapeutics for inherited retinal diseases
Geiger, A., Kennedy, J. G., Staker, L. G., Wensel, T. G., Casson, R. J., & Thomas, P. Q. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101376 · Cited by 11
Kulbay, M., Tuli, N., Akdag, A., Ali, S. K., & Qian, C. X. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144224 · Cited by 13
“In search of an optimization strategy to deliver large transgenes through AAV-based gene therapy, a similar dual AAV vector construct coined “REVeRT” by Riedmayr and colleagues was tested on a small cohort of mice, successfully reconstituting the ABCA4 gene [173].”
MethodUnlocking the secrets of ABEs: the molecular mechanism behind their specificity
Chen, X., McAndrew, M. J., & Lapinaitė, A. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221508 · Cited by 12
Tonetto, E., Cucci, A., Follenzi, A., Bernardi, F., Pinotti, M., & Balestra, D. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.04.020 · Cited by 11
Precise Gene Knock‐In Tools with Minimized Risk of DSBs: A Trend for Gene Manipulation
Liu, Y. H., Kong, J., Liu, G., Li, Z., & Xiao, Y. (2024) · Advanced Science · doi:10.1002/advs.202401797 · Cited by 13
Lee, J. M., Zeng, J., Liu, P., Nguyen, M. A., Loustaunau, D. S., Bauer, D. E., Yılmaz, N. K., Wolfe, S. A., & Schiffer, C. A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1217 · Cited by 10
Zhang, H., Li, Y., Li, J., Li, X., & Li, T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111405 · Cited by 9
“RNP delivery via LNPs enables efficient editing in extrahepatic tissues like retina, with sufficient efficiency to elicit phenotypic responses in post-mitotic cells [167].”
Precision genome editing with DNA base editors
Mawson, S. J., Dunne-Dombrink, K., Pollak, B. R., & Komor, A. C. (2026) · Nature Reviews Methods Primers · doi:10.1038/s43586-026-00478-3 · Cited by 9
The Promises and Pitfalls of CRISPR-Mediated Base Editing in Stem Cells
Wong, P. K., Zamberi, N. N. M., Syafruddin, S. E., Cheah, F., Azmi, N., Law, J. X., & Chua, E. W. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0013 · Cited by 9
A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes
Laoharawee, K., Johnson, M. J., Lahr, W. S., Sipe, C. J., Kleinboehl, E., Peterson, J. J., Lonetree, C.-L., Bell, J. B., Slipek, N. J., Crane, A. T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179749 · Cited by 7
“In addition, we closely examined deploying Cas9 mRNA in place of Cas9 protein to enable the use of rapidly evolving engineering tools, such as base and prime editors where purified proteins are not commercially available or difficult to produce [67].”
BackgroundImproving adenine base editing precision by enlarging the recognition domain of CRISPR-Cas9
Gao, S., Weng, B., Wich, D., Power, L. H., Chen, M., Guan, H., Ye, Z., Xu, C., & Xu, Q. (2025) · Nature Communications · doi:10.1038/s41467-025-57154-5 · Cited by 9
Gottimukkala, K. S. V., Lane, D. D., Cunningham, R. A., Malik, H. S., Jwa, Y., Cassidy, M. E., Castelli, J. M. P., Enstrom, M., Poljakov, K., Gastelum, G. M., et al. (2026) · Gene Therapy · doi:10.1038/s41434-025-00591-0 · Cited by 10
Non-viral gene therapy for Leber’s congenital amaurosis: progress and possibilities
Abdulsalam, L., Mordecai, J., & Ahmad, I. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2443387 · Cited by 7
In vivo adenine base editing ameliorates Rho-associated autosomal dominant retinitis pigmentosa
Hu, S., Chen, Y., Zhou, Y., Cao, T., Liu, S., Ding, C., Xie, D., Liang, P., Huang, L. T., Liu, H., et al. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.12.012 · Cited by 6
Wang, Z., Yuan, H., Yang, L., Ma, L., Zhang, Y., Deng, J., Li, X., Xiao, W., Li, Z., Qiu, J., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127418 · Cited by 5
Engineered ADARs enable precision A-to-G base editing of DNA
Im, H. W., Jeong, B., Lee, Y., Oh, Y. E., Jung, C., Kim, Y. W., Kim, D. Y., Lee, S., Uhm, H., Kim, Y., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03223-z · Cited by 3
Self-citationNegishi, K., Endo, M., Endo, T., & Nishitani, C. (2024) · Plant Biotechnology · doi:10.5511/plantbiotechnology.24.0903a · Cited by 3
“Nevertheless, it is difficult to express the necessary amount of purified base editor for RNP transduction in E. coli , and complex experimental systems, such as those employing human cells, are required (Jang et al. 2021).”
Preparation of high-purity RNPs of CRISPR-based DNA base editors
McAndrew, M. J., King, M. B., & Lapinaitė, A. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.01.019 · Cited by 3
Highly Efficient A-to-G Editing in PFFs via Multiple ABEs
Jing, Q., Liu, W., Jiang, H., Liao, Y., Yang, Q., & Xing, Y. (2023) · Genes · doi:10.3390/genes14040908 · Cited by 4
“In addition, research has revealed that delivery of ABE ribonucleoprotein complexes (RNPs) or mRNA can dramatically reduce random RNA editing events, exhibiting more robust strategy for base editing in mammalian cells [53,54].”
BackgroundEaton, E. J., Wick, B. J., Chacón, J. S., Wang, A. J., Kluesner, M., Barnes, J. T., Kar, B., Wang, M., Johnson, M. J., Skeate, J. G., et al. (2026) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2026.102908 · Cited by 2
“45 46–49 Alternatively, ABE mRNA delivery is widely used for transient base editor expression.”
Heterologous Expression and Purification of a CRISPR-Cas9-Based Adenine Base Editor
Lee, S.-N., Jang, H.-S., & Woo, J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2879-9_10 · Cited by 2
Self-citationEvans, M. M., Liu, S., Krautner, J. S., Seguin, C., Leung, R., & Ronald, J. A. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102248 · Cited by 2
“38,39 We will investigate off-target editing with MCs versus plasmids in future studies.”
Cytosine base editor-DNA binding domain fusions for editing window modulation in the RNP format
Brettmann, E. A., Chen, F., Beishir, S., & Garvey, G. S. (2025) · BMC Biotechnology · doi:10.1186/s12896-025-01020-1 · Cited by 1
Galdikaitė, E., Krušnauskas, R., Henderson, E., & Bujakowska, K. M. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101462 · Cited by 1
“In rd12 mice, subretinal delivery of NG-ABEmax RNP complex formulated with Lipofectamine 2000 achieved precise correction of the Rpe65 mutation with average editing efficiencies of 1.8% in juvenile mice and 1.2% in adults (Jang et al., 2021).”
InfluentialLee, S. J., Nam, B.-G., Hong, S.-A., Jo, D. H., Lee, S.-M., Bae, S., & Kim, J. H. (2026) · Gene Therapy · doi:10.1038/s41434-026-00607-3 · Cited by 2
Self-citationPiñeiro-Silva, C., Bermejo‐Álvarez, P., Garcia-Purriños, F. J., & Gadea, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-49229-0 · Cited by 1
“…mRNA-based systems typically resulting in a longer duration of activity compared to the more transient action of RNPs. Previous studies have shown that the shorter exposure associated with RNP delivery of base editors can lead to reduced editing efficiency relative to mRNA-based approaches 52,53 .”
Highly efficient base editing at PCSK9 and normal human embryo development
Jerabek, S., Jung, C., Kappy, M. D., Zhao, Q., Sung, J., Wang, N., Kim, E., Kim, J., Kulmann, M. I. R., King, M. B., et al. (2026) · Nature · doi:10.1038/s41586-026-11118-x · Cited by 1
Self-citationTranslating base editors: a decade of progress from the bench to the clinic
Gaudelli, N. M., & Komor, A. C. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01548-7 · Cited by 1
Virus-like particle delivery enables orthogonal genome editing in vitro and in vivoPreprint
Shin, S., Nam, B.-G., Park, E. J., Kim, M. G., Cho, C. S., Kim, Y.-W., Lee, S., Kim, J. H., & Sangsu, B. A. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.705092 · Cited by 2
Self-citationA self-inactivating system for AAV-mediated in vivo base editingPreprint
Zuo, Y., Wang, P., Gao, Y., Zhang, C., Zhou, Y., Li, H., Chen, Z., Yang, Z., Xu, J., Zhang, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1663604/v1
Application of Base Editor-Mediated Genome Editing in Mouse Retina
Wu, J., Cho, C. S., Jo, D. H., & Kim, J. H. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2879-9_14
Self-citationGomez, A. M. M., Thulung, L. R., Daby, C. L., Savage, K. S., Clark, K. J., & Ekker, S. C. (2024) · GEN Biotechnology · doi:10.1089/genbio.2024.0016
“17”
Detection and site-specific editing of RNA modifications
Tang, H., Shao, J., Jiang, X., Yan, W., Luo, G., & Weng, X. (2024) · Scientia Sinica Chimica · doi:10.1360/ssc-2024-0244
WITHDRAWN: Codon-Optimized Base Editors Enable Efficient Base Substitution in Non-model AnimalsPreprint
Wang, J., Wang, J., Florea, A., Stewart, R., Ballantyne, M., Tucker, C. S., Houston, R. D., & Robledo, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650635
Current perspectives on gene therapy and its involvement in curing genetic disorders
Nishad, S., Dongare, D. B., Saha, S., Anil, R. D., Srivastava, N., & Dey, A. (2025) · Human Genetics · doi:10.1007/s00439-025-02757-7 · Cited by 1
Jung, Y., Seo, E., Yang, S., Bae, S., Kim, J. H., Jang, H., & Jo, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-10600-2 · Cited by 1
Self-citationAdvances in viral and nonviral delivery systems for therapeutic gene editing
Jiang, W., Jeong, H. C., & Kim, J. H. (2025) · Taiwan Journal of Ophthalmology · doi:10.4103/tjo.tjo-d-25-00068
Self-citationTool-Building and Mechanistic Insights for Cytosolic and Nuclear Delivery of Therapeutic Proteins
Zoltek, M. (2024) · eScholarship (California Digital Library)
Codon-optimized base editors enable efficient base substitution in Atlantic salmon
Wang, J., Wang, J., Florea, A., Stewart, R., Houston, R. D., & Robledo, D. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.01.015
Base editing approaches for the treatment of β-hemoglobinopathies
Antoniou, P. (2021) · theses.fr (ABES) · doi:10.70675/c4dddb32zf8aez4bc3z8cf8zce9a4e808265
Base editing approaches for the treatment of ß-hemoglobinopathies
Hardouin, G. (2022) · theses.fr (ABES) · doi:10.70675/593cd291z9d0ez45a6z82cdz64ffb2e65ff8
Goyal, S., & Vanita, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43986-5.00042-4
Genome and epigenome editing approaches to treat β-hemoglobinopathies
Fontana, L. (2024) · theses.fr (ABES) · doi:10.70675/f1623d8bz5529z4d2dzb255z45ed273f643c
Efficient genome editing in the non-human primate brain using programmable extracellular vesiclesPreprint
Liang, X., Zhou, H., Nizamudeen, Z. A., Kyriakopoulou, E., Evans, A. E., Roudi, S., Estupiñan, H. Y., Rädler, J., Hou, V., Daniel, C. D. W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.05.741964
Mohanna, S. Z. M., Korecki, A. J., Kazemian, P., Lengyell, T. C., Adair, B. A., Leavitt, B. R., & Simpson, E. M. (2026) · Frontiers in Genome Editing · doi:10.3389/fgeed.2026.1910209
“…advantages including the use of chemically modified gRNAs for improved on-target editing (Hendel et al., 2015; Chen et al., 2021), natural clearance to reduce off-target effects (Jang et al., 2021; Liang et al., 2015; Kim et al., 2014), and no risk of genomic integration (Kim et al., 2014).”
Abbas, B., Abbas, A., Khan, I., & Nazeer, S. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110782
Beyond prediction: The evolving role of artificial intelligence in genome editing
Shin, S., Uhm, H., Kim, Y.-W., Im, H. W., & Bae, S. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.08.025
Self-citationChen, B., Nong, B., Lin, S., Yang, Y., Yu, Y., Tan, W., Zhu, T., Pei, Y., Xu, W., Wu, Y., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.10.022
Self-citation
Metadata
- Authors
- Jang, H.-K., Jo, D. H., Lee, S.-N., Cho, C. S., Jeong, Y. K., Jung, Y., Yu, J., Kim, J. H., Woo, J.-S., & Bae, S.
- Affiliations
- Hanyang University (KR)
- Seoul National University (KR)
- Korea University (KR)
- Corresponding author
- Kim, Jeong Hun
- Woo, Jae-Sung
- Bae, Sangsu
- ORCID
- Venue
- Science Advances
- Published
- 2021-08-27
- Volume
- 7
- Issue
- 35
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8397273
- OpenAlex
- W3194942572
- Cited by
- 93
- References
- 51
- Citations by year
- 2026: 17 · 2025: 13 · 2024: 19 · 2023: 23 · 2022: 19 · 2021: 2
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- Korea Research Institute of Bioscience and Biotechnology (KGM5362111)
- National Research Foundation of Korea (2018M3A9H3022412, 2018M3D1A1058826, 2015M3A7B6027946, 2020M3A9I4036074, 2017R1A6A3A04004741, 2018R1C1B6004447, 2020M3A9I4036072)
- Norsk Revmatikerforbund (2021M3A9H3015389, 2020R1A6A1A06046728)
- Technology Innovation Program (20000158)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- base editing, ribonucleoprotein, cytosine base editors, adenine base editors, off-target effects, DNA editing, RNA editing, precise genome editing
- MeSH terms
- Gene Editing, Animals, Cytosine, DNA, Ribonucleoproteins, RNA, Mice, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.